Diabetes Mellitus Type 1 Perspective

 
 
  • Anti-VEGF/PRP Regresses Diabetic Retinopathy Taking a closer look at PROTEUS, an intriguing study in patients with high-risk proliferative diabetic retinopathy.
  • 'Whatever It Takes': Helping Patients Afford Insulin   Anne Peters and Irl Hirsch discuss alternatives to pricey analog insulins.
  • Hypoglycemia, 25 Years After DCCT A new European consortium aims to help clinicians understand the underlying mechanisms and predictors of hypoglycemia in patients with type 1 diabetes.
  • 5 Types of Diabetes: Can New Analysis Make Care Easier?   A new classification system may enable more personalized management approaches and improve outcomes.
  • Congress to Help Medicare Patients Obtain Diabetes Supplies A cost-cutting strategy adopted several years ago, called the competitive bidding program, caused access issues for many patients with diabetes; Congress is now trying to remedy the problem.
  • ADA 2018 Read clinically focused news coverage of key developments from ADA 2018.
  • Choosing Insulin: A New Wrinkle   Dr Arefa Cassoobhoy reviews a whitepaper on the affordability of insulin and how this affects treatment adherence.
  • We Can't Just Give Up on Obesity A pediatric endocrinologist describes the harsh realities of practicing in the South today and calls on the medical profession to redress 'sins of the past.'
  • SGLT2 Inhibitors: Unreal Primary Prevention? These diabetes drugs offer cardiovascular benefits, but only in diabetes patients who already have CV disease, the author argues.
  • AACE 2018 Read clinically focused news coverage of key developments from AACE 2018.
  • DUPC 2018 Read clinically focused news coverage of key developments from DUPC 2018
  • SGLT2 Inhibitors in Type 1 Diabetes Are SGLT2 inhibitors safe and effective in patients with type 1 diabetes?
  • ENDO 2018 Read clinically focused news coverage of key developments from ENDO 2018.
  • Which CGM for Which Diabetes Patient?   Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.
  • New Diabetes Guidelines Fail to Guide   An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
  • Type 2 Diabetes in Kids: Don't Miss It   Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.
  • What Cardiologists Need to Know About New Diabetes Drugs   Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.
  • AHATrials We Did, Trials We Should Do Dr Walton-Shirley reflects on some major studies presented at AHA 2017 and offers a further way to approach each one.
  • 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  • The Lowdown on the Lower GI Tract --More From WCOG at ACG 2017   Dr David Johnson continues to provide his takeaways from this meeting. In part 2, study highlights from the biliary tract and pancreas to the small intestine and colon are covered.